Quellenregister / 210 email Johnson Johnson COVID 19 vaccine development update launch of Phase 3 clinical trials 2 Redacted s.pdf

Quelle · EU-0271

210 email Johnson Johnson COVID 19 vaccine development update launch of Phase 3 clinical trials 2 Redacted s.pdf

Belegkennung: EU-0271
Datum im Bestand: Datum im Beleg
Fundstelle / Umfang: 2 PDF-Seiten
Bestand: EU_Beschaffung

Originalquelle öffnen ↗

https://www.asktheeu.org/request/the_vaccines_procurement_steerin/response/37654/attach/8/210%20email%20Johnson%20Johnson%20COVID%2019%20vaccine%20development%20update%20launch%20of%20Phase%203%20clinical%20trials%202%20Redacted%20s.pdf?cookie_passthrough=1

Prüfsumme der gesicherten Datei

SHA-256: 41ddc2b2b8fbae0c4d896f516b8e49bed7fa8f1cd0f84c4e1a3a0c76409bb250